JTG to Showcase Philadelphia Biotech Companies' Technology Needs at One of the Largest Technology Trade Shows in Japan

The Company Serves as a Link Between Philadelphia Biotech Companies and Untapped Japanese Innovations

23-Sep-2004 - Japan Technology Group (JTG) - a Philadelphia-based Japanese technology licensing firm - will showcase technology needs information for pharmaceutical/biotechnology/life science corporations in the Greater Philadelphia area who seek to obtain untapped innovations emerging from Japanese academic ...

Wilex starts clinical trial with new anti-cancer compound

23-Sep-2004 - Wilex AG, Munich, a privately held biopharmaceutical company dedicated to the development of novel cancer therapies, today announced that it has started a "first into man" clinical Phase I trial with its new oral non-cytotoxic anti-cancer compound WX-671. The open-label dose escalating study ...

Global Genomics ab signs collaboration agreement with Rheoscience A/S

22-Sep-2004 - Global Genomics(SM) AB (Stockholm, Sweden) announced today that Rheoscience A/S (Roedovre, Denmark) has entered into an agreement for the use tangerine® gene expression profiling to study targets in metabolic diseases. Ulf Boberg, CEO at Global Genomics stated, "This agreement is yet another ...

Gambro expands into the emerging market for liver support

21-Sep-2004 - Gambro acquires the business of Teraklin AG, Germany, and expands its intensive care business into the extracorporeal treatments for liver support. The transaction is subject to approval by a creditors' committee of Teraklin. Teraklin develops, manufactures and markets a product line for the ...

Novagali Pharma completes second financing round of 14.2 million euros

Novagali Pharma will use new funds for clinical trials of its ophthalmic products and to develop new applications for its innovative technology

21-Sep-2004 - Evry, France. Novagali Pharma, a drug delivery specialist using cationic emulsions to address ophthalmic and other applications including oncology, announces today the completion of its second round of financing. The total amount raised is EUR 14.2 million. New investors Edmond de Rothschild ...

Aeras Receives CDC Funding to Develop TB Vaccine Trial Sites in India

3 year, $2.7 Million Award to Prepare for Testing New TB Vaccines

20-Sep-2004 - Aeras Global TB Vaccine Foundation today announced a $925,000 cooperative agreement from the US Centers for Disease Control and Prevention to conduct epidemiologic studies in preparation for clinical trials of new tuberculosis (TB) vaccines in India. The funding is renewable for up to three ...

Illumina To Conduct Large-Scale Genotyping Study for North American Rheumatoid Arthritis Consortium

20-Sep-2004 - Illumina, Inc. announced that it has signed a commercial agreement to conduct an extensive, two-phase genotyping study for the North American Rheumatoid Arthritis Consortium (NARAC) to identify genes associated with this complex and debilitating disease. The NARAC study will be led by Peter K. ...

New Business Development Appointments Strengthen ClinPhone's Operations

17-Sep-2004 - ClinPhone Inc, the global leader in electronic clinical trial management solutions announces that Sharon R. Favata and Ronald DiNofa have joined its rapidly expanding commercial operations in the role of Business Development Manager. These new appointments highlight ClinPhone's ambitious ...

Takara Bio: Clinical Development of "Cancer Immunotherapy" jointly performed with CI&H, Chinese Academy of Medical Sciences

17-Sep-2004 - Takara Bio Inc. agreed on August 31, 2004 to undertake clinical development of cancer immunotherapy intended for commercialization jointly with Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Beijing. Presently, in China, too, malignant tumor is the leading cause of death, ...

MediBic Alliance Invests In Strand Genomics

17-Sep-2004 - Bangalore, India. Strand Genomics, leading Bangalore-based Life Sciences Informatics company announced that MediBic Alliance, the investment arm of MediBic of Japan, has taken a minority equity stake in Strand. The Series A investment was closed in September 2002 by lead investor WestBridge ...